SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 01, 2022
Document Date
Dec 31, 2021
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Kassberg Thomas Richard